One 2017 study of people with acute myeloid leukemia (AML) found that vitamin D deficiencies were common among people with AML — and that higher vitamin D levels were linked to better leukemia outcomes.
According to the study authors, the body uses vitamin D to tightly bind cells together, causing increased contact inhibition of cancer, and control mitosis, which may help to prevent the uncontrolled proliferation of white blood cells that is characteristic of leukemia.
The cancers for which the most human data are available are colorectal, breast, prostate, and pancreatic cancer. Numerous epidemiologic studies have shown that higher intake or blood levels of vitamin D are associated with a reduced risk of colorectal cancer (7-10).
In addition to decreasing pro-inflammatory cytokines, vitamin D has been shown to support erythropoiesis by increasing burst-forming unit-erythroid proliferation (BFU-E) and having a synergistic effect with erythropoietin to further enhance erythroid progenitor cell proliferation [18, 19].
Recent studies have also found that Vitamin D is closely associated with cardiovascular diseases, diabetes, cancers, autoimmune diseases, infectious diseases, and others [1, 2].
Particularly in engraftment, a study with adult haematopoietic stem progenitors found that vitamin D supplementation enhanced the bone marrow recovery a 34% higher compared to control cells.
Vitamin D is safe for people affected by lymphoma.
Vitamin D deficiency — when the level of vitamin D in your body is too low — can cause your bones to become thin, brittle or misshapen. Vitamin D also appears to play a role in insulin production and immune function — and how this relates to chronic disease prevention and cancer — but this is still being investigated.
Many cases of leukemia across the globe may be caused by vitamin D deficiency as a result of low sunlight exposure. This is the conclusion of a new study published in PLOS One.
The study identified a process of activating the immune system to fight the leukaemia cells. The team found that immune cells known as macrophages could be programmed to attack the cancer cells through a protein known as STING (Stimulator of interferon genes), a well-established activator of the immune system.
Furthermore, one study examined the effect of vitamin D therapy (10,000 IU/kg) on WBC count in 40 adolescents with vitamin D deficiency. They found no significant impact on WBC total and differential count after four weeks of supplementation.
Leukemia is a type of cancer that affects your blood cells and bone marrow. As with other types of cancer, there's currently no cure for leukemia. People with leukemia sometimes experience remission, a state after diagnosis and treatment in which the cancer is no longer detected in the body.
Dietary Vitamin D Increases Percentages and Function of Regulatory T Cells in the Skin-Draining Lymph Nodes and Suppresses Dermal Inflammation.
Vitamin D insufficiency is common in the United States, with low levels linked in some studies to higher cancer incidence, including non-Hodgkin's lymphoma (NHL).
Some lymphoma treatments use your immune system to help treat the lymphoma. These include: Antibody therapy, which uses man-made antibodies to flag up lymphoma cells and tell your immune system to kill them. Antibody therapy is used to treat many types of lymphoma, usually in combination with chemotherapy.
Oranges are one of the fruits rich in Vitamin D as its juice is fortified with calcium & vitamin D. This is one of the best sources of vitamin D for people who are lactose intolerant and cannot include milk & dairy products in their diet.
How Long Does It Take for Vitamin D to Work? If you have a vitamin D deficiency, you may notice improvements within 4-6 weeks of consistent supplementation. However, that timeframe can vary depending on what your baseline vitamin D levels are.
Current review concluded that supplementation with vitamin D had no significant effect on hemoglobin and ferritin levels while positive effects on transferrin saturation and iron status were observed. Further clinical studies are required to determine the actual effect of this intervention on hemoglobin levels.